✦ LIBER ✦

A single-blinded randomised controlled study to determine the efficacy of Omnilux Revive facial treatment in skin rejuvenation

✍ Scribed by Jaideep Bhat; Jan Birch; Colin Whitehurst; Sean W Lanigan

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 311 KB
Volume: 20
Category: Article
ISSN: 0268-8921
DOI: 10.1007/s10103-005-0330-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled single blind stu

A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania

✍ Helen M. Clark; Michael Berk; Shlomo Brook 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

This study is a randomized controlled trial of 40 patients suering from bipolar aective disorder, manic phase (DSM IV). The patients were treated with either clonazepam or lithium. There were no dierences between the two groups at 4 weeks on any of the ecacy measures, which included the BPRS, MAS, C

The efficacy of cevimeline hydrochloride

The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren’s syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study

✍ K. C. M. Leung; A. S. McMillan; M. C. M. Wong; W. K. Leung; M. Y. Mok; C. S. Lau 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 146 KB

Double-blind, placebo-controlled study t

Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

✍ Francesca Mancini; Roberta Zangaglia; Silvano Cristina; Maria Grazia Sommaruga; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract Drooling is a frequent symptom in Parkinson's disease (PD), occurring in almost 75% of all patients. Although it is now well known that drooling in PD is the result of swallowing difficulties rather than excessive saliva production, few treatments have been developed to reduce it. Clini

Intravenous propafenone: Efficacy and sa

Intravenous propafenone: Efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation—A single-blind placebo-controlled study

✍ Francesco Bellandi; roberto Piero Dabizzi; Fabrizio Cantini; Massimo Natale; Lau 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 499 KB

Efficacy of selegiline add on therapy to

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of

Efficacy of etifoxine compared to loraze

Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice

✍ N. Nguyen; E. Fakra; V. Pradel; E. Jouve; C. Alquier; M-E. Le Guern; J. Micallef 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract Adjustment Disorders With Anxiety (ADWA) account for almost 10% of psychologically motivated consultations in primary care. The aim of this double‐blind randomised parallel group study was to compare (non‐inferiority test) the efficacies of etifoxine, a non‐benzodiazepine anxiolytic dru